The State of Global Air 2019 report, released
on April 3, 2019, brings into one place the latest information on air quality
and health for countries around the globe. It is produced annually by the
Health Effects Institute (HEI) and the Institute for Health Metrics and
Evaluation (IHME) – both in the US - as a source of objective, peer-reviewed
air quality data and analysis.
The report presents the latest information on
worldwide air pollution exposures and health impacts. It draws from the most
recent evidence produced as part of the Global Burden of
Disease (GBD) project of IHME.
Key global
messages of the report:
· More
than 90 percent of the world’s population lives in areas where fine particle levels exceed WHO Guideline
for healthy air.
· Air
pollution is the fifth leading risk factor for mortality worldwide. Each year, more
people die from air pollution-related diseases than from road traffic injuries or
malaria.
· In
2017, air pollution is estimated to have contributed to close to 5 million deaths
globally — nearly 1 in every 10 deaths.
· Air
pollution exposures, including exposure to outdoor fine particulate matter (PM2.5),
household air pollution (HAP), and ozone, have been linked with increased hospitalizations,
disability, and early death from respiratory diseases, heart disease, stroke,
lung cancer, and diabetes. Most (82%) deaths are from chronic non-communicable
diseases.
· In
2017, exposure to PM2.5 was the third leading risk factor for deaths and years
of healthy life lost due to type 2 diabetes, after high blood sugar and high body
mass index.
· Life
expectancy: Air pollution collectively reduced life expectancy by 1 year and 8
months on average worldwide, a global impact rivaling that of smoking. This
means a child born today will die 20 months sooner, on average, than would be
expected in the absence of air pollution.
· Ambient
PM2.5: In 2017, the highest annual average exposures to PM2.5 (population-weighted
concentrations) were in South Asia, led by Nepal (100 μg/m3), India (91 μg/m3),
Bangladesh (61 μg/m3), and Pakistan (58 μg/m3).
· The
region with the second-highest average PM2.5 exposure was western sub-Saharan
Africa with 59 μg/m3.
· In
East Asia, China continues to experience the highest population exposures to PM2.5
(53 μg/m3). However, PM2.5 levels have declined by nearly 20% since the
implementation of stringent air pollution controls in 2013.
· Household
Air Pollution: Nearly half of the world’s population — a total of 3.6 billion
people — were exposed to household air pollution in 2017.
· Globally,
the proportion of people cooking with solid fuels has declined from about 64%
in 2005 to 47% in 2017. However, disparities persist, and less-developed countries
continue to suffer the highest exposures to household air pollution.
· Ozone
contributed to approximately 472,000 deaths globally from COPD (chronic obstructive pulmonary disease) in
2017.
Key
messages with respect to India:
· Air
pollution is the 3rd leading risk factor for mortality, accounting for almost 13%
of deaths (1.2 million) in India in 2017 alone.
· Air
pollution exposures, including exposure to outdoor particulate matter (PM2.5)
and household air pollution (HAP), have been linked to increased
hospitalizations, disability, and early death from respiratory diseases, heart
disease, stroke, lung cancer, and diabetes. Exposure to ambient ozone is linked
to COPD.
· Air
pollution is the 3rd leading risk factor in India in 2017, after only dietary
risks and high blood pressure. Individually, outdoor air pollution and
household air pollution are ranked as the 4th and 10th leading risk factors.
· The
entire Indian population lives in areas with PM2.5 concentrations above the WHO
Air Quality Guideline of 10 μg/m3, and only about 15% of the population lives
in areas with PM2.5 concentrations below the WHO’s least-stringent target of 35
μg/m3.
· There
were 673,100 deaths due to exposure to outdoor PM2.5, and more than 481,700
deaths due to exposure to HAP.
· Exposure
to outdoor PM accounted for a loss of nearly 1 year and 6 months in life expectancy,
and exposure to HAP accounted for a loss of nearly 1 year and 2 months.